Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Evotec: Global Player der Biotech
Evotec: Global Player der Biotech
Liebe Leser, zuletzt hat Evotec extrem starke Zahlen vorlegen und die Erwartungen der Anleger deutlich übertreffen können. Möglich sind derartige Ergebnisse dank zahlreicher Partnerschaften mit....
Pfizer steigert Umsatz und Ergebnis
Pfizer steigert Umsatz und Ergebnis
Liebe Leser, der US-Pharmakonzern Pfizer hat auch begünstigt durch einen Milliardenzukauf im vergangenen Herbst bei Umsatz und Ergebnis deutliche Zuwachsraten verbuchen können. Wie der AstraZeneca-Rivale
Johnson & Johnson: Wieder auf Wachstumskurs?
Johnson & Johnson: Wieder auf Wachstumskurs?
Johnson & Johnson (J&J) gehört zu den weltweit führenden Herstellern von Gesundheitsprodukten. Die Angebotspalette umfasst Medikamente, Hygiene- und Pflegeartikel sowie medizintechnische Instrumente. Bekannte
Johnson & Johnson steigert die Umsatzerlöse
Johnson & Johnson steigert die Umsatzerlöse
Liebe Leser, der US-Amerikanische Pharmazie- und Konsumgüterhersteller Johnson & Johnson hat zwischen April und Juni seine Umsätze verbessern können. Wie das Unternehmen mitteilte, stiegen die Einnahmen im
Pfizer langt ordentlich zu!
Pfizer langt ordentlich zu!
Liebe Leser, naja wenn es mit dem großen nicht klappt, muss der kleinere hinhalten. Nach der geplatzten Megafusion mit dem Irischen Pharmariese Allergan, greift sich Pfizer nun an den Rivalen Anacor. Die
Pfizer: Ganz stark!
Pfizer: Ganz stark!
Lieber Leser, die gescheiterte Übernahme von Allergan schien der Pfizer-Aktie einen empfindlichen Dämpfer verpasst zu haben – von wegen! Nachdem der Pharmakonzern jüngst glänzende Zahlen fürs erste Quartal
Der Biotech-Sektor im Aufwind und was das mit dem geplatzten Pfizer/Allergan-Deal zu tun hat
Der Biotech-Sektor im Aufwind und was das mit dem geplatzten Pfizer/Allergan-Deal zu tun hat
Liebe Leser, nun ist es amtlich. Obama hat den Pfizer/Allergan-Deal platzen lassen wie eine Blase. Der seit November 2015 geplante, größte Deal der Geschichte wurde gestern im Laufe des Tages von Pfizer abgesagt.
Pfizer/ Allergan: Was geht denn da ab?
Pfizer/ Allergan: Was geht denn da ab?
Liebe Leser, die Nachrichten um den möglicherweise geplatzten Deal zwischen dem Botox-Hersteller Allergan und dem einem der größten Arzneimittelhersteller Pfizer scheinen sich zu verdichten, leider weniger
Want $1,000 in Dividend Income? Here's How Much You Have to Invest in Pfizer Stock: https://g.foolcdn.com/editorial/images/782654/dividend-sign.jpg
Want $1,000 in Dividend Income? Here's How Much You Have to Invest in Pfizer Stock

Pfizer (NYSE: PFE) may not be the must-have pharmaceutical investment it was at one point. If your priority is reliable divided income, however, the drugmaker remains a rock-solid pick. Not only has

Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip?: https://g.foolcdn.com/editorial/images/782642/wall-street-analyst-getty.jpg
Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip?

The past few years have been tough ones for investors holding shares of Pfizer (NYSE: PFE). The Big Pharma stock is down by more than half from the peak it set in late 2021.

Pfizer's stock price was

3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in July: https://g.foolcdn.com/editorial/images/782398/dividend-investor-4-getty.jpg
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in July

The benchmark S&P 500 index keeps breaking new records thanks in large part to a handful of stocks at the top. Luckily for income-seeking investors, there are some highly reliable dividend stocks

1 Underwhelming Stat That May Have You Thinking Twice About Buying Pfizer's Stock: https://g.foolcdn.com/editorial/images/782112/team-of-traders-working-in-an-office.jpg
1 Underwhelming Stat That May Have You Thinking Twice About Buying Pfizer's Stock

Pfizer (NYSE: PFE) can be a polarizing stock to own right now. Its future remains hazy given that it is facing some troubling patent cliffs and revenue from its COVID-19 vaccine is dwindling. But at

2 High-Yielding Healthcare Stocks to Buy With $1,000 in July: https://g.foolcdn.com/editorial/images/782176/individual-investors-at-home-getty.jpg
2 High-Yielding Healthcare Stocks to Buy With $1,000 in July

It's been a big year for most stocks, with the S&P 500 index up about 24% over the past 12 months. A rising market is wonderful for the stocks already in your portfolio, but finding new investment

2 Ultra-High-Yield Dividend Stocks Billionaires Are Buying Left and Right: Could They Be Smart Buys for You in July?: https://g.foolcdn.com/editorial/images/781786/investor-with-computer-getty.jpg
2 Ultra-High-Yield Dividend Stocks Billionaires Are Buying Left and Right: Could They Be Smart Buys for You in July?

If you're an investor who doesn't already have access to billions in capital, you could probably learn a few things from the folks who do. Luckily, keeping tabs on the world's most successful

Is Pfizer Stock a Buy?: https://g.foolcdn.com/editorial/images/781505/pfizer_logo_on_glass_pfe.jpg
Is Pfizer Stock a Buy?

Shares of pharmaceutical giant Pfizer (NYSE: PFE) have been steadily sliding lower over the past year as revenue and profits from the pandemic's vaccine boom dry up. Today, the stock has seemingly

2 Beaten-Down Dividend Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade: https://g.foolcdn.com/editorial/images/781634/wall-street-analyst-with-laptop-getty.jpg
2 Beaten-Down Dividend Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade

The benchmark S&P 500 index is up an exciting 25.8% over the past year, but many of its components haven't participated in the gains. Nvidia and other members of the "Magnificent Seven" have been

2 Stocks Down More Than 30% to Buy Right Now: https://g.foolcdn.com/editorial/images/781632/gettyimages-638638994.jpg
2 Stocks Down More Than 30% to Buy Right Now

The S&P 500 is soaring as this bull market roars on, but some stocks, even those that have rebounded in recent times, still are trading at much lower levels than in the past. In fact, two stocks

Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk?: https://g.foolcdn.com/editorial/images/781329/doctors-at-table.jpg
Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk?

It's obvious why Pfizer (NYSE: PFE) is eager to produce a medicine like Wegovy, Novo Nordisk's (NYSE: NVO) smash-hit obesity therapy that's essentially a slightly different version of its type 2

Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks: https://g.foolcdn.com/editorial/images/781284/a-person-delivering-a-presentation-getty.jpg
Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks

Would you like to widen the stream of passive income you can expect each year? Managing rental property is an option, but most retirees find this method less passive than they would like it to be.

Is UnitedHealth Group Stock a Millionaire Maker?: https://g.foolcdn.com/editorial/images/780725/a-couple-smiling-and-talking-with-an-advisor.jpg
Is UnitedHealth Group Stock a Millionaire Maker?

Making a million dollars from a single stock sounds like it could be an unrealistic goal. But if you pick a good growth stock, which also pays a dividend, and hold on to it for the long haul, it's

3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold: https://g.foolcdn.com/editorial/images/781093/investor-dark-room-devices-getty.jpg
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold

Investors looking for high-yield dividend stocks to buy now should turn their attention toward the healthcare sector: Three relatively reliable drugmakers are trading near their 52-week lows.

Their

Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb: https://g.foolcdn.com/editorial/images/780869/high-yield.jpg
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb

When it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent names often come to mind: Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY).

Both companies

3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade: https://g.foolcdn.com/editorial/images/780482/investor-checking-stocks-getty.jpg
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade

The S&P 500 is up an incredible 25% over the past 12 months, but not every stock in the benchmark index has participated in the rally. A handful of terrific healthcare stocks have fallen more than

Is It Too Late to Buy Pfizer Stock?: https://g.foolcdn.com/editorial/images/780402/scientists-confer-in-lab.jpg
Is It Too Late to Buy Pfizer Stock?

Are Pfizer's (NYSE: PFE) best days behind it? If the stock's critics are to be believed, the answer is an emphatic "yes, obviously," with issues like its recent stint of unprofitability and a

Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?: https://g.foolcdn.com/editorial/images/780172/scientists-smiling-and-shaking-hands.jpg
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?

Johnson & Johnson reigned as the largest healthcare company in the world for years. UnitedHealth Group also took a turn at the top. However, the title now belongs to Eli Lilly (NYSE: LLY) -- and it